Issued Patents All Time
Showing 1–25 of 37 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 12134636 | Immunoglobulins and uses thereof | Mark J. Macielag, Raymond J. Patch, Rui Zhang, Martin A. Case, Mark Wall +9 more | 2024-11-05 |
| 11767354 | Antibody-coupled cyclic peptide tyrosine tyrosine compounds as modulators of neuropeptide Y receptors | Mark J. Macielag, Raymond J. Patch, Rui Zhang, Martin A. Case, Shamina M. Rangwala +9 more | 2023-09-26 |
| 11591379 | Antibody-coupled cyclic peptide tyrosine tyrosine compounds as modulators of neuropeptide Y receptors | Mark J. Macielag, Raymond J. Patch, Rui Zhang, Martin A. Case, Shamina M. Rangwala +9 more | 2023-02-28 |
| 11401315 | Immunoglobulins and uses thereof | Mark J. Macielag, Raymond J. Patch, Rui Zhang, Martin A. Case, Shamina M. Rangwala +9 more | 2022-08-02 |
| 10968265 | Antibody-coupled cyclic peptide tyrosine tyrosine compounds as modulators of neuropeptide Y receptors | Mark J. Macielag, Raymond J. Patch, Rui Zhang, Martin A. Case, Shamina M. Rangwala +9 more | 2021-04-06 |
| 10858413 | Immunoglobulins and uses thereof | Mark J. Macielag, Raymond J. Patch, Rui Zhang, Martin A. Case, Mark Wall +9 more | 2020-12-08 |
| 10787495 | Immunoglobulins and uses thereof | Mark J. Macielag, Raymond J. Patch, Rui Zhang, Martin A. Case, Shamina M. Rangwala +9 more | 2020-09-29 |
| 10640544 | Antibody-coupled cyclic peptide tyrosine tyrosine compounds as modulators of neuropeptide Y receptors | Mark J. Macielag, Raymond J. Patch, Rui Zhang, Martin A. Case, Shamina M. Rangwala +9 more | 2020-05-05 |
| 10428134 | Immunoglobulins and uses thereof | Mark J. Macielag, Raymond J. Patch, Rui Zhang, Martin A. Case, Shamina M. Rangwala +9 more | 2019-10-01 |
| 9182414 | Methods for identifying a GLP-1 secretagogue | Zhi-Liang Chu | 2015-11-10 |
| 9017949 | Method of screening for compounds useful in the treatment of insulin resistance, impaired glucose tolerance or diabetes | Yaron Hakak | 2015-04-28 |
| 8883714 | Pharmaceutical compositions comprising GPR119 agonists which act as peptide YY (PYY) secretagogues | Zhi-Liang Chu, Robert M. Jones | 2014-11-11 |
| 8580526 | Methods of using GPR119 receptor to identify compounds which stimulate glucose-dependent insulinotropic peptide secretion | Zhi-Liang Chu | 2013-11-12 |
| 8486646 | Methods of using a G protein-coupled receptor to identify peptide YY (PYY) secretagogues | Zhi-Liang Chu, Robert M. Jones | 2013-07-16 |
| 8354241 | Methods for identifying a GLP-1 secretagogue | Zhi-Liang Chu | 2013-01-15 |
| 8198232 | Combination therapy for the treatment of diabetes and conditions related thereto and for the treatment of conditions ameliorated by increasing a blood GLP-1 level | Zhi-Liang Chu, Hussien Al-Shamma, Robert M. Jones | 2012-06-12 |
| 8101626 | GPR119 receptor agonists in methods of increasing bone mass and of treating osteoporosis and other conditions characterized by low bone mass, and combination therapy relating thereto | Zhi-Liang Chu, Juerg Lehmann, Robert M. Jones | 2012-01-24 |
| 8097452 | Human orphan G protein-coupled receptors | Ruoping Chen | 2012-01-17 |
| 8039219 | Method of using GPR35 to identify metabolic-stabilizing compounds | Zhi-Liang Chu | 2011-10-18 |
| 8030270 | Methods for identifying GLP-1 secretagogues | Zhi-Liang Chu, Hussien Al-Shamma, Robert M. Jones | 2011-10-04 |
| 8026074 | Methods of using GPR119 to identify compounds useful for increasing bone mass in an individual | Zhi-Liang Chu | 2011-09-27 |
| 8026212 | Methods of preparing pharmaceutical compositions comprising GPR119 agonists having the effect of glucose-dependent insulinotropic peptide secretatgogues | Zhi-Liang Chu | 2011-09-27 |
| 8022034 | Combination therapy for the treatment of diabetes and conditions related thereto and for the treatment of conditions ameliorated by increasing a blood GLP-1 level | Zhi-Liang Chu, Hussien Al-Shamma, Robert M. Jones | 2011-09-20 |
| 8017574 | Methods of preparing pharmaceutical compositions comprising GPR119 agonists having the effect of glucose-dependent insulinotropic peptide secretagogues | Zhi-Liang Chu | 2011-09-13 |
| 8003597 | Combination therapy for the treatment of diabetes and conditions related thereto and for the treatment of conditions ameliorated by increasing a blood GLP-1 level | Zhi-Liang Chu, Hussein A. Al-Shamma, Robert M. Jones | 2011-08-23 |